Picture: Drew Angerer/Staff members/Getty Photos The Residence Oversight Committee launched a report this week criticizing drugmakers’ stock buybacks, discovering that fourteen big pharmaceutical businesses spent
Picture: Drew Angerer/Staff members/Getty Photos The Residence Oversight Committee launched a report this week criticizing drugmakers’ stock buybacks, discovering that fourteen big pharmaceutical businesses spent